All In Biotech

Drugs by condition

Drugs approved for huntington's disease chorea

Brand-name prescription drugs and biologics whose FDA label lists huntington's disease chorea as an approved use. Matched on the label phrases: "Huntington".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

0

Still marketed, NDA or BLA

Drug classes

0

Novel drugs

0

New molecular entities and new biologics

In development

6

Investigational drugs in Phase 2 or 3

All approved drugs for huntington's disease chorea, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 0 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

No current brand-name label names this in its indications. Try another name for the condition, or a broader term.

Drugs in development for huntington's disease chorea

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • SKY-0515Phase 33 trials

    Skyhawk Therapeutics, Inc. · Huntington Disease, Huntingtons Disease, Huntington's Disease (HD)

  • PridopidinePhase 32 trials

    Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease

  • ER2001Phase 21 trial

    ExoRNA Bioscience · Huntington Disease

  • MBF-015Phase 21 trial

    Medibiofarma S.L. · Huntington Disease

  • TominersenRO7234292, RG6042Phase 21 trial

    Roche (Genentech) · Huntington Disease

  • VO659Phase 21 trial

    Vico Therapeutics B. V. · Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease

More on huntington's disease chorea: recruiting trials · published research

Related in neurology: Alzheimer's disease · Parkinson's disease · Multiple sclerosis · Epilepsy and seizures · Migraine · ALS (amyotrophic lateral sclerosis) · Myasthenia gravis · Spinal muscular atrophy · Duchenne muscular dystrophy · Tardive dyskinesia

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.